Tumor Necrosis Factor News and Research

RSS
Study finds sizeable position for Actemra in rheumatoid arthritis treatment paradigm

Study finds sizeable position for Actemra in rheumatoid arthritis treatment paradigm

Gene involved in susceptibility and resistance to TB identified

Gene involved in susceptibility and resistance to TB identified

Idera Pharmaceuticals presents IMO-3100 TLR antagonist mechanism of action data at Keystone conference

Idera Pharmaceuticals presents IMO-3100 TLR antagonist mechanism of action data at Keystone conference

Study shows CEL-2000 vaccine blocks RA progression in mice

Study shows CEL-2000 vaccine blocks RA progression in mice

Researchers find differences in the biology of lung cancer between men and women

Researchers find differences in the biology of lung cancer between men and women

Biogen Idec reports 2009 fourth quarter and full year earnings

Biogen Idec reports 2009 fourth quarter and full year earnings

Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published

Preliminary study results of ExThera Medical's Seraph extracorporeal affinity therapy published

Researchers uncover new mechanism to protect individuals from serious complications of obesity

Researchers uncover new mechanism to protect individuals from serious complications of obesity

New biomarker may predict treatment outcomes in RA patients

New biomarker may predict treatment outcomes in RA patients

Genentech's ACTEMRA approved to treat RA

Genentech's ACTEMRA approved to treat RA

Significant opportunity for alternative ulcerative colitis biological therapy

Significant opportunity for alternative ulcerative colitis biological therapy

University of Western Ontario receives grant to conduct randomized trial for Crohn's disease

University of Western Ontario receives grant to conduct randomized trial for Crohn's disease

2010 Dr. Paul Janssen Award for Biomedical Research open for nomination

2010 Dr. Paul Janssen Award for Biomedical Research open for nomination

Ohr Pharmaceutical to develop OHR/AVR118 for cachexia treatment

Ohr Pharmaceutical to develop OHR/AVR118 for cachexia treatment

Cancer-fighting protein successfully placed directly into solid tumors and turned on

Cancer-fighting protein successfully placed directly into solid tumors and turned on

Research team identifies five new gene regions that raise the risk of childhood-onset IBD

Research team identifies five new gene regions that raise the risk of childhood-onset IBD

TNF-alpha inhibitors ranked top for reducing biologics spend

TNF-alpha inhibitors ranked top for reducing biologics spend

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

Pregnant women with symptoms of depression have a stronger biological reaction to the seasonal flu vaccine

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from CIMZIA WELCOME trial to be presented at the ACG meeting